Theramex
Manufacturing · United Kingdom · 201-500 Employees
View Company Info for Free
Overview
Headquarters
1 Holbein Pl Fl 1, London, Greater Londo...Phone Number
(650) 564-4941Website
www.theramex.comRevenue
$135.8 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
3
3
1
1
1
1
About Theramex
Theramex is a global specialty pharmaceutical company focused solely on women's health, providing a diverse portfolio of products designed to support women through every stage of life. The company offers various treatments related to contraception, menopause, osteoporosis, and fertility, aimed at addressing the unique health needs of women. With a commitment to delivering impactful solutions, Theramex serves an international audience, ensuring accessible care across multiple regions. Led by a skilled leadership team from their headquarters in London, Theramex drives value for both patients and healthcare partners.Explore more
Theramex Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Theramex your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Theramex is spiking on competitors!
Click to see if Theramex had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Theramex, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Theramex recently announced quarterly report
Funding: Get notified immidiatlly once Theramex has new funding data
Product Launch: Get notified when Theramex launches new products
Check if Theramex has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Theramex
Recommended Actions
Reach out to Masked Content who joined Theramex as Masked Content
Find more new buyers
Compare Similar Companies to Theramex
Compare insights from companies similar to Theramex, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Theramex is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Theramex is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Theramex.
Theramex Tech Stack
A closer look at the technologies used by Theramex
Most Recent Scoops
Open Position
Open Position
Open Position
Open Position
Hiring Plans
Hiring Plans
Theramex News & Media
Theramex Announces Agreement to Acquire the European Rights to Duphaston® and Femoston® From Viatris, Inc.
LONDON--(BUSINESS WIRE)--Theramex, a leading global speciality pharmaceutical company dedicated to women’s health, is pleased to announce that it has entered into an agreement to acquire the European rights to Duphaston® and Femoston® from Viatris Inc. Viatris retains the rights for Australia and Japan. The transaction is subject to customary regulatory and anti-trust approvals. “As we continue to strengthen our commitment to women’s health and improve our patients access to high quality treatmTheramex Enters Into an Exclusive Licensing Agreement With Radius Health Inc, to Commercialise ELADYNOS® ▼in the European Economic Area, the United Kingdom, Australia and Brazil
LONDON--(BUSINESS WIRE)--Theramex, a leading global speciality pharmaceutical company dedicated to women’s health, has entered into an exclusive licensing agreement with Radius Health, Inc., for the rights to commercialise ELADYNOS® (abaloparatide), a novel bone forming agent indicated for the treatment of osteoporosis in postmenopausal women at increased risk of fractures. Theramex will commercialise and distribute ELADYNOS® on an exclusive basis in the European Economic Area, the United KingdObsEva Announces European Commission Marketing Authorization for Yselty® (linzagolix), an Oral GnRH Antagonist, for the Treatment of Uterine Fibroids
-Yselty® (linzagolix) is the first and only approved GnRH antagonist to provide flexible dosing options with and without hormonal add-back therapy- -Theramex to commercialize Yselty®; ObsEva to receive royalties on commercial sales, as well as development, commercial, and sales-based milestone payments- -In the United States, the New Drug Application (NDA) for linzagolix is currently under review by the Food and Drug Administration (FDA), with a Prescription Drug User Fee Act (PDUFA) target actiTheramex Launches Non-hormonal Femarelle® on the 12th of May
LONDON--(BUSINESS WIRE)--Theramex will be joining the 20th International Society of Gynecological Endocrinology (ISGE) congress from the 11th-14th May in Florence, Italy. The ISGE is a non-profit organization whose purpose is to drive more awareness around important gynecology topics ensuring a dialogue between interested parties. Theramex are very proud to introduce Femarelle® which Theramex will commercialize in Italy, France, Spain, Germany, UK, Belgium, Poland and Australia. Femarelle® is a
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Theramex
Sign Up For FreeTo access detailed company insights
Theramex is a global specialty pharmaceutical company focused solely on women's health, providing a diverse portfolio of products designed to support women through every stage of life. The company offers various treatments related to contraception, menopause, osteoporosis, and fertility, aimed at addressing the unique health needs of women. With a... Read More
